A Phase 2 Single-Arm Study of Gemcitabine in Combination with Oxaliplatin in Pediatric Patients with Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS Tumors

Update Il y a 4 ans
Reference: EUCTR2005-005219-36

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to assess the antitumor activity, as measured by objective response rate, of the gemcitabine plus oxaliplatin combination in pediatric patients with neuroblastoma. The antitumor activity of the miscellaneous solid non-CNS tumor cohort will be assessed by describing the responses seen in each tumor type.


Inclusion criteria

  • Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS Tumors

Links